We provide you with 20 years of free, institutional-grade data for TERN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TERN. Explore the full financial landscape of TERN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Terns Pharmaceuticals(NASDAQ:TERN) 
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases. It develops TERN-101, a liver-distributed and non-bile acid far...
Share this website to your friends
The information provided in this report about TERN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.